' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | Your page doesn't have meta description |
h1 tags | Aytu BioPharma |
h2 tags | Aytu announces formation of new Scientific Advisory Board to support development of AR101 for VEDS. Aytu expands reach into ADHD Therapeutic Market. Good health starts early. Aytu pediatric medicines. A family of innovative products that’s perfect for yours. Aytu to sponsor the upcoming PREVEnt Trial to evaluate the effectiveness of AR101 (enzastaurin) in patients with VEDS. See the light. Healight study for COVID-19. ADHD affects people of all ages and all stages of life. Helping children get off to a healthier start and a better life. A growing portfolio |
Site Speed | 2.1482582092285 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| aytubio.com | A | IN | 3600 | |
| aytubio.com | NS | IN | 21600 | ns57.domaincontrol.com |
| aytubio.com | NS | IN | 21600 | ns58.domaincontrol.com |
| aytubio.com | SOA | IN | 3600 | |
| aytubio.com | MX | IN | 1800 | d179846a.ess.barracudanetworks.com |
| aytubio.com | MX | IN | 1800 | d179846b.ess.barracudanetworks.com |
| aytubio.com | TXT | IN | 3600 | |
| aytubio.com | TXT | IN | 3600 |